Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,578.03
-21.2968-1.33%
Number of Gainers:- -
Number of Losers:7
Number of Flat:- -
PE:- -
High:1,598.74
Open:1,598.63
Low:1,570.99
Close:1,599.33
Volume:60.92M
Turnover:5.19B
Market Cap:1.64T
Float Cap:1.58T

Loading ...

Viking Therapeutics Shares Down 15% After Co Prices Upsized Stock, Convertible Offerings

THOMSON REUTERS
·
Sep 24

U.S. Stocks on the MOVE-Everpure, Dropbox, Darden Restaurants

Reuters
·
Sep 24

Viking Therapeutics, - Offering Size Increased to $275 Mln Common Stock and $225 Mln Notes

THOMSON REUTERS
·
Sep 24

Eli Lilly Gets FDA OK for Onswik Once-Weekly Insulin Injection

Dow Jones
·
Sep 24

Eli Lilly - Onswik Kwikpen to be Available in U.S. in 500 Units/Ml and 1,000 Units/Ml Concentrations

THOMSON REUTERS
·
Sep 24

U.S. Food and Drug Administration (FDA) Approves Lilly's Onswik™ (Insulin Efsitora Alfa-Gobe), a Once-Weekly Basal Insulin Injection Treatment for Adults Living with Type 2 Diabetes

THOMSON REUTERS
·
Sep 24

Novo Nordisk's new strategy hinges on something it cannot manufacture: investor confidence

Deep News
·
Sep 24

Sino Biopharmaceutical Stock Slips 1.8% in Hong Kong

Dow Jones
·
Sep 24

Viking Therapeutics Shares Down 8.7% Premarket After Co Announces Planned Stock, Convertible Offerings

THOMSON REUTERS
·
Sep 24

Leerink Partners Remains a Hold on Amgen (AMGN)

TIPRANKS
·
Sep 24

RBC Capital Remains a Hold on Pfizer (PFE)

TIPRANKS
·
Sep 24

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 24

BridgeBio's Heart Drug Shows Superior Real-World Results Over Pfizer's Rival Treatment

Stock News
·
Sep 24

Viking Therapeutics $200M Spot Secondary; price range $35.00-$38.00

TIPRANKS
·
Sep 24

Viking Therapeutics Plans USD 200 Million Convertible Senior Notes Offering Due 2032

Reuters
·
Sep 24

Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior Notes

THOMSON REUTERS
·
Sep 24

Viking Therapeutics, - to Offer $200 Mln Common Stock and $200 Mln Convertible Notes Due 2032

THOMSON REUTERS
·
Sep 24

Viking Therapeutics, - Proceeds to Fund Vk2735, Vk3019 Clinical Development and General Corporate Purposes

THOMSON REUTERS
·
Sep 24

Eli Lilly & Co. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Sep 24

Novo Nordisk A/S Stock (NVO) Closed Down by 3.12% on Sep 23: Key Drivers Unveiled

TradingKey
·
Sep 24